
|Videos|August 14, 2020
Reconstructing the Nosology of Psychiatric Medications
Author(s)John J. Miller, MD
Drug mechanisms of action are evolving. An area in psychiatry that has become increasingly important clinically is discussed here.
Advertisement
John J. Miller, MD, discusses an increasingly important and clinically relevant issue in psychiatry. According to Dr Miller, "We are at the point in time where we have a much greater sophistication and understanding of what is happening when a drug enters into the brain circuit and interfaces with receptors."
Dr Miller is Medical Director, Brain Health, Exeter, NH; Editor in Chief, Psychiatric Times; Staff Psychiatrist, Seacoast Mental Health Center, Exeter, NH; Consulting Psychiatrist, Exeter Hospital, Exeter, NH; Consulting Psychiatrist, Insight Meditation Society, Barre, MA.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
DT120 (Lysergide) Shows Rapid, Lasting Relief for Generalized Anxiety in Phase 3 Trial
2
Experience With Xanomeline/Trospium in an Acute Inpatient Setting Treating Individuals With Schizophrenia
3
FDA Approves Tauklarify (MK-6240) For Tau Pathology Detection in Alzheimer Disease
4
New Ingrezza Data Shows Improved Quality of Life and Daily Functioning in Tardive Dyskinesia
5








